Click to view this email in a browser
 
  

rx-360-logo.jpg  Flash Report

A Non-Profit Organization
www.Rx-360.org

09-October-2010 

The Partnership for Safe Medicines held a forum on counterfeit prescription drugs.

Keynote Address:  

Food and Drug Administration (FDA) Commissioner Margaret Hamburg gave her assessment of the problem of counterfeit drugs and talked about what the FDA is doing to combat it.

To view the keynote address 1 go to:
http://www.c-spanvideo.org/program/295894-4

 

Counterfeit Prescription Drugs:

Scott LaGanga opened the discussion with an overview of the issue. Other speakers included scholars, government officials, and an AIDS patient who accidentally used counterfeit drugs to treat his symptoms. Following their remarks, panelists responded to audience members' questions. Rick Roberts, patient/consumer Walt Bogdanich, New York Times Dr. Salvatore J. Giorgianni, Men's Health Network Marsha K. Millonig, American Pharmacists Association

To view the discussion of Panel go to:
http://www.c-spanvideo.org/program/295894-1

 

Counterfeit Drug Profits Part 1:

Panelists talked about who benefits from unsafe drugs. Topics included enforcement and prosecution efforts and difficulties, and the trafficking of controlled prescription drugs such as Oxycontin. This program was briefly interrupted by a pro forma Senate session and is continued in program identification number 295895-101. This program was part of a Partnership for Safe Medicines forum on counterfeit prescription drugs. 10:30a-12p Panel 2: Who's Benefiting from Unsafe Drugs? Moderator: Dr. Bryan Liang Charlie Cichon, National Association of Drug Diversion Investigators Nancy Kennedy, Food & Drug Administration, Office of Criminal Investigations Rob Hill, Drug Enforcement Agency Jeffrey Gren, U.S. Department of Commerce

To view the discussion of Panel go to:
http://www.c-spanvideo.org/program/295894-2

 

Counterfeit Drug Profits Part 2:

Who's Benefiting from Unsafe Drugs? Moderator: Dr. Bryan Liang Charlie Cichon, National Association of Drug Diversion Investigators Nancy Kennedy, Food & Drug Administration, Office of Criminal Investigations Rob Hill, Drug Enforcement Agency Jeffrey Gren, U.S. Department of Commerce

To view the discussion of panel go to:
http://www.c-spanvideo.org/program/295894-101

 

Anti-Counterfeit Drug Efforts:

Panelists talked about efforts and progress in fighting counterfeit drugs. This program was joined in progress. 1-2:30p Panel 3: Who's Making Progress Against Counterfeit Drugs? Moderator: Tom Kubic Dr. Michael Green, Centers for Disease Control and Prevention Hugo Bonar, Irish Medicines Board Richard Halverson, Immigration & Customs Enforcement, National Intellectual Property Rights Coordination Center John Gray, Healthcare Distribution Management Association.

To view the discussion of Panel go to:
http://www.c-spanvideo.org/program/295894-3

 

 

Rx-360 | An International Supply Chain Organization - Washington D.C.
E-Mail:
info@rx-360.org
Forward this message to a friend




If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Rx-360
1500 K Street NW, Suite 1100
Washington, DC 20005

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!